Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 3
2001 3
2002 4
2003 6
2004 6
2005 2
2006 8
2007 6
2008 2
2009 7
2010 6
2011 3
2012 9
2013 14
2014 9
2015 7
2016 7
2017 8
2018 6
2019 6
2020 8
2021 5
2022 3
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Oncolytic virotherapy.
Russell SJ, Peng KW, Bell JC. Russell SJ, et al. Among authors: peng kw. Nat Biotechnol. 2012 Jul 10;30(7):658-70. doi: 10.1038/nbt.2287. Nat Biotechnol. 2012. PMID: 22781695 Free PMC article. Review.
Lentiviral vector targeting.
Larochelle A, Peng KW, Russell SJ. Larochelle A, et al. Among authors: peng kw. Curr Top Microbiol Immunol. 2002;261:143-63. doi: 10.1007/978-3-642-56114-6_7. Curr Top Microbiol Immunol. 2002. PMID: 11892245 Review. No abstract available.
Viral vector targeting.
Peng KW, Russell SJ. Peng KW, et al. Curr Opin Biotechnol. 1999 Oct;10(5):454-7. doi: 10.1016/s0958-1669(99)00009-9. Curr Opin Biotechnol. 1999. PMID: 10508637 Review.
Designing and building oncolytic viruses.
Maroun J, Muñoz-Alía M, Ammayappan A, Schulze A, Peng KW, Russell S. Maroun J, et al. Among authors: peng kw. Future Virol. 2017 Apr;12(4):193-213. doi: 10.2217/fvl-2016-0129. Epub 2017 Mar 31. Future Virol. 2017. PMID: 29387140 Free PMC article. Review.
Oncolytic Viruses: Priming Time for Cancer Immunotherapy.
Russell L, Peng KW, Russell SJ, Diaz RM. Russell L, et al. Among authors: peng kw. BioDrugs. 2019 Oct;33(5):485-501. doi: 10.1007/s40259-019-00367-0. BioDrugs. 2019. PMID: 31321623 Free PMC article. Review.
Oncolytic Measles Virotherapy and Opposition to Measles Vaccination.
Russell SJ, Babovic-Vuksanovic D, Bexon A, Cattaneo R, Dingli D, Dispenzieri A, Deyle DR, Federspiel MJ, Fielding A, Galanis E, Lacy MQ, Leibovich BC, Liu MC, Muñoz-Alía M, Miest TC, Molina JR, Mueller S, Okuno SH, Packiriswamy N, Peikert T, Raffel C, Van Rhee F, Ungerechts G, Young PR, Zhou Y, Peng KW. Russell SJ, et al. Among authors: peng kw. Mayo Clin Proc. 2019 Sep;94(9):1834-1839. doi: 10.1016/j.mayocp.2019.05.006. Epub 2019 Jun 22. Mayo Clin Proc. 2019. PMID: 31235278 Free PMC article. Review.
Reengineering paramyxovirus tropism.
Hadac EM, Peng KW, Nakamura T, Russell SJ. Hadac EM, et al. Among authors: peng kw. Virology. 2004 Nov 24;329(2):217-25. doi: 10.1016/j.virol.2004.08.036. Virology. 2004. PMID: 15518802 Free article.
Antibody-targeted cell fusion.
Nakamura T, Peng KW, Vongpunsawad S, Harvey M, Mizuguchi H, Hayakawa T, Cattaneo R, Russell SJ. Nakamura T, et al. Among authors: peng kw. Nat Biotechnol. 2004 Mar;22(3):331-6. doi: 10.1038/nbt942. Epub 2004 Feb 15. Nat Biotechnol. 2004. PMID: 14990955
Oncolytic Virotherapy: A Contest between Apples and Oranges.
Russell SJ, Peng KW. Russell SJ, et al. Among authors: peng kw. Mol Ther. 2017 May 3;25(5):1107-1116. doi: 10.1016/j.ymthe.2017.03.026. Epub 2017 Apr 6. Mol Ther. 2017. PMID: 28392162 Free PMC article. Review.
122 results